Rücklab – Psychiatry research at Karolinska Institutet
Research on OCD and related disorders, precision psychiatry, psychiatric genetics, suicide prevention, stress and PTSD
Ekaterina Ivanova has received not one but TWO grants from Swedish Society of Medicine (Svenska Läkaresällskapet), the post doc grant and the project grant.
Both of the grants are for the Bergen 4 Day treatment project, an RCT testing the non-inferiority, speed of recovery, and cost-effectiveness of Bergen 4-Day Treatment (B4DT) for obsessive compulsive disorder (OCD), compared to gold-standard CBT.
Read more about the Bergen 4 Day treatment-project here.
Congratulations Katja! 🎺🎺🎺
Sunny midsummer was great, but we are even happier that Max Sannemalm just joined our group!
Max is a licensed psychologist and will be joining us as the project coordinator for the randomized controlled non-inferiority trial study comparing the Bergen 4-Day Treatment (B4DT) to gold-standard CBT for OCD.
The Bergen 4-Day Treatment (B4DT) is a new concentrated treatment for OCD developed by Gerd Kvale and Bjarne Hansen from Bergen. In B4DT, patients receive ERP at a clinic during 4 consecutive days. The B4DT has shown to achieve remission in around 70% of patients when delivered in regular care in several uncontrolled treatment trials, and one randomized controlled trial (RCT) including a self-help group and a waitlist group. However, it has yet to be directly compared to gold-standard CBT.
The study will test the non-inferiority, speed of recovery, and cost-effectiveness of B4DT, compared to gold-standard.
To summarize: Exciting things ahead, and welcome to the group, Max!
Rücklab - Psychiatry research at Karolinska Institutet 